Public Health Product Hops
Bill of Health
APRIL 24, 2023
On a panel together, we each presented on topics relating to product hopping, but from very different perspectives. Glenn Cohen’s Health Law Policy, Bioethics, and Biotechnology Workshop at HLS. In fact, the FDA continues to encourage the development of ADFs for opioids while exploring the development for ADFs of CNS stimulants.
Let's personalize your content